A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : OND

Search Conditions:
Search Keyword : OND
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: OND
Appearance Frequency: 519 time(s)
Long forms: 48

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
other neurological diseases
(286 times)
Neurology
(205 times)
MS (193 times)
CSF (129 times)
ELISA (21 times)
1976 Mixed lymphocyte reaction in multiple sclerosis.
ondansetron
(59 times)
Neoplasms
(20 times)
DEX (6 times)
GRA (5 times)
i.v (5 times)
1991 Development of a co-culture system with induced HepG2 cells and K562 cells for examining drug metabolism in vitro. Studies with cyclophosphamide, ondansetron and cisplatin.
other non-inflammatory neurological diseases
(29 times)
Neurology
(20 times)
CSF (13 times)
MS (13 times)
GBS (5 times)
1990 Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.
Operation New Dawn
(28 times)
Rehabilitation
(7 times)
OIF (25 times)
OEF (24 times)
PTSD (11 times)
2011 Sexuality among wounded veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND): Implications for rehabilitation psychologists.
optic nerve diameter
(14 times)
Ophthalmology
(6 times)
ONSD (8 times)
TOS (3 times)
ICP (2 times)
1998 Echographic measurements of the retrobulbar optic nerve in normal and glaucomatous eyes.
oligonucleotide
(11 times)
Chemistry Techniques, Analytical
(4 times)
dsDNA (1 time)
GQ (1 time)
HEX (1 time)
2005 Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.
ondansetron hydrochloride
(9 times)
Neoplasms
(5 times)
BSA (1 time)
DRG (1 time)
DSC (1 time)
1999 Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
obese non-diabetic
(8 times)
Metabolism
(7 times)
OD (3 times)
ADRP (1 time)
AT (1 time)
2001 Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals.
optic nerve drusen
(8 times)
Ophthalmology
(7 times)
CNV (3 times)
OCT (2 times)
PDT (2 times)
2003 Submacular surgery for choroidal neovascularization secondary to optic nerve drusen.
10  optic nerve disk
(7 times)
Ophthalmology
(6 times)
IOP (4 times)
NPG (4 times)
OA (2 times)
1997 [The impact of endovascular intervention on visual functions in patients with traumatic carotid-cavernous anastomosis].
11  oxanorbornadiene
(7 times)
Biochemistry
(4 times)
Ab (1 time)
Boc (1 time)
crDA (1 time)
2009 Thiol-selective fluorogenic probes for labeling and release.
12  optic nerve decompression
(4 times)
Otolaryngology
(2 times)
IIH (1 time)
IOP (1 time)
TON (1 time)
1998 Endoscopic optic nerve decompression: the Graz experience.
13  optic nerve disease
(4 times)
Ophthalmology
(2 times)
DEC (2 times)
CSM (1 time)
RNB (1 time)
1993 Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
14  Oxanorbornadiene dicarboxylate
(3 times)
Chemistry
(2 times)
BSA (1 time)
2012 Degradable conjugates from oxanorbornadiene reagents.
15  oxygen nutrient deprivation
(3 times)
Brain
(2 times)
hAGS (1 time)
ibeAGS (1 time)
NMDA (1 time)
2006 Persistent tolerance to oxygen and nutrient deprivation and N-methyl-D-aspartate in cultured hippocampal slices from hibernating Arctic ground squirrel.
16  October-November-December
(2 times)
Biophysics
(2 times)
AMJ (1 time)
AO (1 time)
DTR (1 time)
2011 Early-season warning of soybean rust regional epidemics using El Nino Southern/Oscillation information.
17  other neurological disorder patients
(2 times)
Allergy and Immunology
(1 time)
CSF (1 time)
IgG (1 time)
MRI (1 time)
2007 CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
18  other neurological disorders or symptoms
(2 times)
Neurology
(2 times)
CDMS (1 time)
CPMS (1 time)
CSF (1 time)
1987 Acute multiple sclerosis exacerbations are characterized by low cerebrospinal fluid suppressor/cytotoxic T-cells.
19  other neuromuscular disorders
(2 times)
Communicable Diseases
(1 time)
aGAAb (1 time)
aSF (1 time)
CFS (1 time)
1994 Studies on enterovirus in patients with chronic fatigue syndrome.
20  oxidized nanodiamond
(2 times)
Chemistry
(1 time)
CND (1 time)
FTIR (1 time)
PPA (1 time)
2015 Surface functionalization of nanodiamond with phenylphosphonate.
21  oxidized ND
(2 times)
Carbohydrates
(1 time)
FTIR (2 times)
ND (2 times)
CS (1 time)
2017 Enhanced mechanical properties of chitosan/nanodiamond composites by improving interphase using thermal oxidation of nanodiamond.
22  antagonists--ondansetron
(1 time)
Psychopharmacology
(1 time)
OXZ (1 time)
WSE (1 time)
1998 An anxiolytic-like effect of ondansetron disappears in oxazepam-tolerant rats.
23  non-demyelinating neurological disease
(1 time)
Chemistry
(1 time)
MS (1 time)
SSPE (1 time)
1982 Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.
24  O not determined
(1 time)
Veterinary Medicine
(1 time)
STEC (1 time)
2015 Shiga toxin-producing Escherichia coli O157, O26 and O111 in cattle faeces and hides in Italy.
25  obese non-diabetic participants
(1 time)
Endocrinology
(1 time)
11beta-HSD (1 time)
D cortisol (1 time)
LND (1 time)
2014 Hepatic 11beta-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.
26  OND and LGNh were significantly lower in the POAG group
(1 time)
Ophthalmology
(1 time)
Ch (1 time)
LGNh (1 time)
MRI (1 time)
2017 MR Imaging of the Anterior Visual Pathway in Primary Open-Angle Glaucoma: Correlation with Octopus 101 Perimetry and Spectralis Optical Coherence Tomography Findings.
27  ondansetron alone
(1 time)
Neoplasms
(1 time)
ODC (1 time)
1993 Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy.
28  ondansetron HCl
(1 time)
Biomedical Engineering
(1 time)
EE (1 time)
i.n (1 time)
SLNs (1 time)
2012 Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation.
29  ondansetron HCl dihydrate
(1 time)
Chemistry
(1 time)
SR (1 time)
2015 Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
30  ondansetron hydrochloride dihydrate
(1 time)
Chemistry
(1 time)
ODF (1 time)
UD (1 time)
2018 A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
31  Ophthalmic Nursing Diploma
(1 time)
Nursing
(1 time)
RN (1 time)
2003 A study of supervised practice from the perspective of the supervisor and the supervised.
32  optic nerve dysfunction
(1 time)
Neurology
(1 time)
CFPD (1 time)
MS (1 time)
PVER (1 time)
1984 Critical frequency of photic driving in the diagnosis of multiple sclerosis.
33  organic neurological diseases
(1 time)
Neurology
(1 time)
MS (1 time)
1982 Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
34  organic nitrogen detector
(1 time)
Environmental Health
(1 time)
LC-OCD-OND (1 time)
SEC-OCD (1 time)
2011 Characterisation of aquatic humic and non-humic matter with size-exclusion chromatography--organic carbon detection--organic nitrogen detection (LC-OCD-OND).
35  originally nondeprived
(1 time)
Neurology
(1 time)
LGN (1 time)
OD (1 time)
1998 Morphology of single geniculocortical afferents and functional recovery of the visual cortex after reverse monocular deprivation in the kitten.
36  other CNS diseases
(1 time)
Neurology
(1 time)
aCL (1 time)
IgG (1 time)
IgM (1 time)
1998 Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.
37  other disease controls
(1 time)
Allergy and Immunology
(1 time)
BADGE (1 time)
CSF (1 time)
HAM/TSP (1 time)
2006 Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.
38  other nervous diseases
(1 time)
Medicine
(1 time)
Anti-MBP (1 time)
CMP (1 time)
CVD (1 time)
1995 [Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein in serum and CSF of patients with diseases of the nervous system].
39  other nervous system disorders
(1 time)
Neurology
(1 time)
AGE (1 time)
CSF (1 time)
IEF (1 time)
2000 Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index.
40  other neurodegenerative diseases
(1 time)
Neurology
(1 time)
CCD (1 time)
CCSVI (1 time)
MS (1 time)
2013 Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
41  other neurodevelopmental disorders
(1 time)
Pediatrics
(1 time)
ASD (1 time)
CA (1 time)
ID (1 time)
2015 Adaptive profiles in autism and other neurodevelopmental disorders.
42  other neurologic disease controls
(1 time)
Neurology
(1 time)
ADEM (1 time)
EDSS (1 time)
GFAP (1 time)
2010 Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
43  other neurological diseases without dementia
(1 time)
Geriatrics
(1 time)
Abeta1-42 (1 time)
CSF (1 time)
MCI (1 time)
2012 Performance of abeta1-40, abeta1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
44  other neurological disorders without cognitive impairment
(1 time)
Neurology
(1 time)
Abeta1-42 (1 time)
CSF (1 time)
OD (1 time)
2010 Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
45  other neurological noninflammatory and non-neurodegenerative diseases
(1 time)
Alzheimer Disease
(1 time)
AD (1 time)
AUC (1 time)
CI (1 time)
2018 A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
46  other neuropsychiatric disorders
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
CI (1 time)
CPM (1 time)
NPD (1 time)
2006 Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care.
47  other non-inflammatory diseases
(1 time)
Neurology
(1 time)
CSF (1 time)
MS (1 time)
pDCs (1 time)
2011 Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse.
48  other non-psychotic disorders
(1 time)
Psychiatry
(1 time)
AD (1 time)
2007 Adolescent adjustment disorder: precipitant stressors and distress symptoms of 89 outpatients.